In its latest publication, Polaris Market Research presents an in-depth analysis of the Aerospace Plastics Market. It captures the momentum, disruption, and evolution unfolding across this fast-moving industry. Offering a balanced mix of data-driven analysis and strategic insight, the report tracks the market’s historical development, evaluates its present state, and provides...

In 2024, the global glioblastoma multiforme (GBM) treatment market was valued at USD 2.84 billion, and under prevailing pipelines and investment assumptions the market is forecast to grow at a compound annual growth rate (CAGR) of 9.5 % over the coming decade. This robust expansion reflects intensifying R&D in neuro-oncology, growing incidence of GBM globally, and regulatory impetus for...

The global coworking spaces market is expanding at a steady and sustainable pace, reflecting the shifting balance of how organizations and individuals view office infrastructure. Valued at USD 14.2 billion in 2024, the market is expected to achieve a CAGR of 8.20% from 2025 to 2034, marking a structural evolution in the commercial real estate ecosystem. This growth is underpinned by...

"Regional Overview of Executive Summary CRISPR Gene-Editing Market by Size and Share The global CRISPR gene-editing market size was valued at USD 1.83 billion in 2024 and is expected to reach USD 14.74 billion by 2032, at a CAGR of 29.8% during the forecast period A consistent market research report like CRISPR Gene-Editing Market report extends reach to the...

Precision Medicine Market Overview: Trends, Growth, and Future Outlook The global precision medicine market is rapidly gaining momentum, fueled by groundbreaking advancements in genomics, biotechnology, and data-driven healthcare innovations. Valued at approximately USD 74.6 billion in 2025, this market is projected to soar to about USD 225.3 billion by 2033, expanding...

The U.S. Clinical Laboratory Tests Market, valued at USD 52.77 billion in 2024, is projected to grow at a CAGR of 6.1% during 2025–2034, reaching USD 95.24 billion by 2034. The market’s growth is being driven by rapid advancements in diagnostic testing, increased adoption of laboratory automation, and the rising emphasis on personalized...

The Europe Clinical Laboratory Tests Market, valued at USD 68.54 billion in 2024, is expected to grow at a CAGR of 2.21% during 2025–2034, reaching USD 85.21 billion by 2034. The market growth is fueled by the increasing adoption of molecular diagnostics, expansion of laboratory automation, and growing investment in healthcare infrastructure across Europe. The...

The global advanced cancer diagnostics market was valued at USD 58.09 billion in 2024 and is forecasted to grow at a CAGR of 9.1% through 2034. The market’s structural segmentation by technology, application, and end-user reveals a rapidly diversifying ecosystem characterized by product differentiation, value chain optimization, and clinical integration. Continuous innovation across...

Oncology Drugs Market: Trends, Growth Drivers, and Future Outlook The global oncology drugs market has emerged as one of the most dynamic and rapidly evolving segments in the pharmaceutical industry. With cancer ranking as the second leading cause of death worldwide, the demand for effective oncology treatments continues to soar. Increasing prevalence of cancer, advancements in...

Market Overview The global oncology-based molecular diagnostics market is witnessing steady and sustained growth, reflecting the growing role of molecular-level technologies in transforming cancer care. Valued at USD 3.66 billion in 2024, the market is projected to reach USD 6.12 billion by 2034, expanding at a CAGR of 5.3% from 2025 to 2034. This growth...